NCT01685372View on ClinicalTrials.gov

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2017

Conditions
Solid Organ Transplant Recipient (Liver, Kidney, Heart)Rheumatologic DisorderHuman Immunodeficiency Virus (HIV)Bone Marrow Transplant (BMT)Dialysis
Interventions
BIOLOGICAL

Fluzone High Dose

A single-dose of high-dose influenza vaccine will be administered to subjects randomized to this arm

BIOLOGICAL

Fluzone

A single-dose of standard-dose influenza vaccine will be administered to subjects randomized to this arm

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
collaborator

Colorado Clinical & Translational Sciences Institute

OTHER

lead

University of Colorado, Denver

OTHER

NCT01685372 - Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults | Biotech Hunter | Biotech Hunter